At Colair, we take the time to understand your goals, your timeline, and what side effects you may be experiencing from your GLP-1 medications so we can recommend the right combination of skin care treatments for you
Observational studies and clinical trials have further supported the role of GLP-1RAs in AD management
The reviewed data show that maternal exposure to GLP-1 agonists causes reduced embryonic-fetal survival, increases in major congenital anomalies, reduced fetal weight/growth, retardation of ossification, irregular ossification and skeletal variants in mice, rats and rabbits
Carbs & Fat: These are balanced targets not strict rules
Their ability to improve metabolic health, reduce systemic inflammation, and lower surgical complication rates makes them valuable in optimizing patient outcomes